![Jacek Antas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 683 002 $ al 31/07/2026
Jacek Antas is currently Chairman at Helix BioPharma Corp.
Formerly, Mr. Antas was Chief Executive Officer at Antas Srl.
Education includes a graduate degree from Warsaw School of Economics.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HELIX BIOPHARMA CORP. 0,84 % | 15/12/2025 | 638.320 ( 0,84 % ) | 683 002 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HELIX BIOPHARMA CORP. | Presidente | 18/04/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Antas Srl
 Antas Srl Engineering & ConstructionIndustrial Services Provides integrated installation, maintenance, operation and fuel management services of heating systems | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Helix BioPharma Corp.
 Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Warsaw School of Economics
 Warsaw School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antas Srl
Antas Srl Engineering & ConstructionIndustrial Services Provides integrated installation, maintenance, operation and fuel management services of heating systems | Industrial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
